153 related articles for article (PubMed ID: 34624486)
1. Identification of immune infiltration-related LncRNA FAM83C-AS1 for predicting prognosis and immunotherapy response in colon cancer.
Li G; Feng H; Chen Q; Xue C; Li M; Liu X; Ma S
Transpl Immunol; 2021 Dec; 69():101481. PubMed ID: 34624486
[TBL] [Abstract][Full Text] [Related]
2. LncRNA ST7-AS1 is a Potential Novel Biomarker and Correlated With Immune Infiltrates for Breast Cancer.
Zhang Z; Zhang H; Li D; Zhou X; Wang J; Zhang Q
Front Mol Biosci; 2021; 8():604261. PubMed ID: 33912584
[No Abstract] [Full Text] [Related]
3. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.
Chen B; Lu X; Zhou Q; Chen Q; Zhu S; Li G; Liu H
PLoS One; 2023; 18(8):e0290031. PubMed ID: 37582104
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.
Yang W; Ge F; Lu S; Shan Z; Peng L; Chai J; Liu H; Li B; Zhang Z; Huang J; Hua Y; Zhang Y
Front Med (Lausanne); 2021; 8():795427. PubMed ID: 34926534
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of OTX2-AS1 is Associated With Immune Infiltration and Predicts Prognosis of Gastric Cancer.
Han QL; Cui Z; Wang Q; Pang F; Li D; Wang D
Technol Cancer Res Treat; 2023; 22():15330338231154091. PubMed ID: 36740995
[TBL] [Abstract][Full Text] [Related]
6. The oncogenic role of LncRNA FAM83C-AS1 in colorectal cancer development by epigenetically inhibits SEMA3F via stabilizing EZH2.
Xue W; Wang F; Han P; Liu Y; Zhang B; Gu X; Wang Y; Li M; Zhao Y; Cui B
Aging (Albany NY); 2020 Oct; 12(20):20396-20412. PubMed ID: 33109776
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma.
Lin Y; Li Y; Chen Y; Zhang Z
Medicine (Baltimore); 2022 Oct; 101(42):e31314. PubMed ID: 36281164
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic significance of long noncoding RNA SSTR5-AS1 in patients with gastric cancer.
Cheng Y; Di J; Wu J; Shi HT; Zou BC; Zhang Y; Xie DH
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5385-5390. PubMed ID: 32495873
[TBL] [Abstract][Full Text] [Related]
10. Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in Breast Cancer.
Yi W; Shen H; Sun D; Xu Y; Feng Y; Li D; Wang C
Med Sci Monit; 2021 Dec; 27():e934522. PubMed ID: 34880202
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
12. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Xiao R; Yang M; Tan Y; Ding R; Li D
Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
[TBL] [Abstract][Full Text] [Related]
13. High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration.
Wang HY; Xie Y; Du H; Luo B; Li Z
PeerJ; 2023; 11():e16104. PubMed ID: 37810780
[TBL] [Abstract][Full Text] [Related]
14. Value of long non-coding RNA HAS2-AS1 as a diagnostic and prognostic marker of glioma.
You A; Gu J; Wang J; Li J; Zhang Y; Rao G; Ge X; Zhang K; Gao X; Wang D
Neurologia (Engl Ed); 2024 May; 39(4):353-360. PubMed ID: 38616063
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma.
Liao C; Wang A; Ma Y; Liu H
Medicine (Baltimore); 2021 Oct; 100(40):e27473. PubMed ID: 34622876
[TBL] [Abstract][Full Text] [Related]
16. Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer.
Lin Y; Xiao Y; Liu S; Hong L; Shao L; Wu J
BMC Med Genomics; 2022 Oct; 15(1):221. PubMed ID: 36280825
[TBL] [Abstract][Full Text] [Related]
17. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
Xu Q; Wang Y; Huang W
Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322
[TBL] [Abstract][Full Text] [Related]
18. LncRNA ELF3-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Chen T; Zhu C; Wang X; Pan Y
Can J Gastroenterol Hepatol; 2021; 2021():8323487. PubMed ID: 34336727
[TBL] [Abstract][Full Text] [Related]
19. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Huang W; Liu Z; Li Y; Liu L; Mai G
J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
